Your browser doesn't support javascript.
loading
Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
Gubler, D B; Ahlstrom, C R; Liu, L; Zhou, J F; Parker, C J; Rodgers, G M.
  • Gubler DB; Department of Medicine, University of Utah, Salt Lake City 84123, USA.
Thromb Haemost ; 74(6): 1573-7, 1995 Dec.
Article en En | MEDLINE | ID: mdl-8772239
ABSTRACT
Vascular endothelium regulates multiple aspects of platelet function through secretion of a variety of substances, including von Willebrand factor, nitric oxide, and prostacyclin (PGI2). The objective of this study was to determine whether procoagulant albumin (P-A1), a modified form of albumin present in normal human plasma could modulate endothelial cell secretion of these substances. P-A1 did not affect constitutive secretion of von Willebrand factor or nitric oxide, but did increase PGI2 secretion in a time- and concentration-dependent manner. Pre-treatment of endothelial cells with aspirin, or use of suramin, a broad-specificity inhibitor, prevented the response to P-A1. Prostaglandin H synthase-2 contributed to the P-A1-induced PGI2 secretion. These results indicate that in addition to inducing tissue factor activity and reducing protein C activation and fibrinolysis, P-A1 also modulates vascular endothelial cell PGI2 secretion, and potentially, platelet function.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Plaquetas / Factores de Coagulación Sanguínea / Albúmina Sérica / Endotelio Vascular / Epoprostenol Límite: Humans Idioma: En Año: 1995 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Plaquetas / Factores de Coagulación Sanguínea / Albúmina Sérica / Endotelio Vascular / Epoprostenol Límite: Humans Idioma: En Año: 1995 Tipo del documento: Article